Contact this trialFirst, we need to learn more about you.
Antiretroviral Therapy
Biktarvy After Kidney Transplant for HIV
Recruiting3 awardsPhase 4
New York, New York
This trial will test a new HIV drug, Biktarvy, to see if it is safe and effective. People with HIV who have had a kidney transplant will be switched from their current medication to Biktarvy. The trial will last 48 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.